Otizole 0.5293 mg (Polymyxin B Sulfate SUSPENSION) 0.5293 MG

Otizole 0.5293 mg is an otic suspension containing Polymyxin B Sulfate, designed for ear health in animals. This medication is formulated to address ear infections and promote ear canal health. Ideal for pet owners seeking reliable ear care solutions.

Strength

0.5293 MG

Pack Size

15/30/100ML

Manufacturer / TM Owner

CAN-VET ANIMAL HEALTH SUPPLIES LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Otizole 0.5293 mg is primarily used for the treatment of ear infections in animals. Polymyxin B Sulfate, the active ingredient, is known for its antibacterial properties, making it effective in managing bacterial ear infections. This otic suspension is often recommended for pets experiencing discomfort or inflammation in the ear canal.

Side Effects

When used as directed, Otizole 0.5293 mg may help reduce symptoms associated with ear infections, such as itching, redness, and discharge. Some animals may experience temporary discomfort upon application, which typically subsides as the medication takes effect.

Precautions & Warnings

Always consult a veterinarian before using Otizole 0.5293 mg, especially if the animal has a history of ear conditions or allergies. Avoid contact with the eyes and ensure the ear canal is clean before application. Store the suspension at room temperature and keep it out of reach of children and pets.

Avoid Interactions

Otizole 0.5293 mg may interact with other ear medications or treatments. It is advisable to inform your veterinarian about any other medications your pet is currently taking. Avoid using this suspension in conjunction with other otic products unless directed by a professional.

Frequently Asked Questions

Otizole 0.5293 mg is used to treat bacterial ear infections in animals, helping to alleviate symptoms like itching and discharge.

Otizole 0.5293 mg should be administered directly into the ear canal as directed by a veterinarian. Ensure the ear is clean before application.

Common side effects may include temporary discomfort or irritation at the application site. If symptoms persist, consult a veterinarian.

Otizole 0.5293 mg may interact with other ear medications. Consult a veterinarian before combining treatments.

Store Otizole 0.5293 mg at room temperature and keep it out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.